These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5739203)

  • 1. [Results of the use of heparin in the complex treatment of patients with diabetes mellitus].
    Lesnichiĭ AV
    Ter Arkh; 1968 Jun; 40(6):108-11. PubMed ID: 5739203
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of heparin on the level of sugar and lipids in the blood in diabetic patients].
    Bozadzhieva ; V'rbanov G
    Probl Endokrinol Gormonoter; 1966; 12(4):45-8. PubMed ID: 6002013
    [No Abstract]   [Full Text] [Related]  

  • 3. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Attempts of modification of the serum lipid fractions in diabetics].
    Krámer M; Balogh P
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(5):345-51. PubMed ID: 5731589
    [No Abstract]   [Full Text] [Related]  

  • 5. [Abnormalities of serum lipids and lipoproteins in diabetes mellitus].
    Hase M; Nakano E
    Saishin Igaku; 1972 Mar; 27(3):510-4. PubMed ID: 5021395
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intermediate substrates in different stages of compensation of diabetes mellitus].
    Kr'stev I; Panaiotov Ch; Penev M; Runev N; Tsoncheva A; Misheva A
    Vutr Boles; 2001; 33(1):37-9. PubMed ID: 11785087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of various heparin preparations on lipoproteins in hemodialysis patients: a multicentre study.
    Kronenberg F; König P; Neyer U; Auinger M; Pribasnig A; Meisl T; Pinter G; Dieplinger H
    Thromb Haemost; 1995 Oct; 74(4):1025-8. PubMed ID: 8560405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipids and lipoproteins in diabetes mellitus].
    Syllaba J
    Vnitr Lek; 1975 Nov; 21(11):1078-83. PubMed ID: 1198952
    [No Abstract]   [Full Text] [Related]  

  • 9. [The blood serum content of cholesterol, phospholipids, proteins and lipoproteins of patients with diabetes mellitus during treatment with sulfanyl-urea derivatives].
    SIL'NITSKII PA
    Sov Med; 1963 Jan; 26():38-42. PubMed ID: 13992812
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood lipids and lipoproteins in prolonged diabetes].
    CUGUDDA E; AGNISETTA S; ANGIOLETTI D
    Atti Accad Fisiocrit Siena Med Fis; 1956; 3():xviii-xxii. PubMed ID: 13445578
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
    Romics L; Karádi I; Rozenberczki M; Kammerer L
    Acta Med Acad Sci Hung; 1982; 39(3-4):117-23. PubMed ID: 6764327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytochemical study of leukocytic lipids in relation to cholesterol rate in diabetes mellitus].
    POLOSA P; CASOLO A; DI SALVO C
    Boll Soc Ital Biol Sper; 1953 Jul; 29(7):1346-9. PubMed ID: 13140510
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lipomicrons, cholesterol and total lipids in the blood in diabetes; their importance in the pathogenesis of atherosclerosis].
    ALBRIEUX AS; ROCCA F
    Arch Urug Med Cir Espec; 1955; 46(1-3):17-24. PubMed ID: 13269279
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in lipoprotein metabolism in patients with diabetes mellitus and the effect on lipid profile in diabetics].
    Mudríková T; Tkác I; Takác M
    Vnitr Lek; 1994 Apr; 40(4):250-4. PubMed ID: 8184588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Behavior of the total blood cholesterol and the serum beta-lipoproteins in various forms of diabetes mellitus].
    GASTALDI F; REGAZZINI A
    Folia Endocrinol Mens Incretologia Incretoterapia; 1961 Feb; 14():60-87. PubMed ID: 13703874
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the effect of subcutaneous heparin on blood coagulability and blood lipids in diabetic patients].
    Ghanem MH; Tawfik S; Guirgis FK; el-Sawy M
    Therapeutique; 1971 May; 47(5):473-6. PubMed ID: 5562482
    [No Abstract]   [Full Text] [Related]  

  • 17. beta-Thalassaemia and factors affecting the metabolism of lipids and lipoproteins.
    Papanastasiou DA; Siorokou T; Haliotis FA
    Haematologia (Budap); 1996; 27(3):143-53. PubMed ID: 14653451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of the correction of carbohydrate metabolism on serum lipids and lipoproteins in insulin-dependent diabetics].
    Romics L; Karádi I; Rozenberczki M; Kammerer L
    Orv Hetil; 1980 Dec; 121(51):3113-6. PubMed ID: 7012750
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma clearing capacity & changes in blood cholesterol levels after intravenous injections of heparin in diabetes & atherosclerosis].
    STORK A; KUCEROVA L
    Dtsch Med Wochenschr; 1957 Aug; 82(35/I):1410-3. PubMed ID: 13461649
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lipid profile of the diabetic. Actual modalities and perspectives].
    Moulin P; Berthezene F
    Diabete Metab; 1989; 15(3):142-5. PubMed ID: 2668055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.